Control subjects with NGT | T2DM without atherosclerosisa | T2DM with atherosclerosisa | ||||
---|---|---|---|---|---|---|
β | P | β | P | β | P | |
SBPa | − 0.032 | 0.763 | − 0.040 | 0.686 | 0.103 | 0.301 |
DBPa | 0.132 | 0.218 | 0.033 | 0.746 | − 0.035 | 0.723 |
TGa | 0.142 | 0.169 | 0.364 | < 0.001 | 0.400 | < 0.001 |
TCa | − 0.055 | 0.596 | 0.019 | 0.848 | 0.080 | 0.419 |
LDL-Ca | − 0.032 | 0.755 | 0.039 | 0.696 | − 0.050 | 0.625 |
HDL-Ca | − 0.142 | 0.158 | 0.083 | 0.392 | 0.072 | 0.466 |
Fasting plasma glucosea | 0.125 | 0.216 | 0.083 | 0.395 | − 0.008 | 0.932 |
Fasting insulina | − 0.075 | 0.461 | 0.102 | 0.301 | 0.183 | 0.67 |
HOMA-IRa | − 0.027 | 0.789 | 0.109 | 0.265 | 0.158 | 0.117 |
HbA1ca | 0.025 | 0.810 | 0.141 | 0.143 | − 0.117 | 0.243 |
Duration of diabetesa | – | – | 0.242 | 0.013 | 0.294 | 0.002 |
c-IMT (mm)a | 0.100 | 0.324 | 0.333 | 0.001 | 0.322 | 0.001 |